Candriam S.C.A. Has $64.43 Million Holdings in Xylem Inc. $XYL

Candriam S.C.A. grew its holdings in shares of Xylem Inc. (NYSE:XYL) by 13.0% in the 2nd quarter, Holdings Channel reports. The fund owned 498,043 shares of the industrial products company’s stock after buying an additional 57,332 shares during the period. Candriam S.C.A.’s holdings in Xylem were worth $64,430,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Hanson & Doremus Investment Management increased its position in Xylem by 0.9% during the 2nd quarter. Hanson & Doremus Investment Management now owns 8,516 shares of the industrial products company’s stock worth $1,102,000 after purchasing an additional 77 shares in the last quarter. Princeton Global Asset Management LLC increased its holdings in shares of Xylem by 2.1% during the second quarter. Princeton Global Asset Management LLC now owns 3,801 shares of the industrial products company’s stock worth $492,000 after buying an additional 79 shares in the last quarter. Ascent Wealth Partners LLC increased its holdings in shares of Xylem by 0.7% during the first quarter. Ascent Wealth Partners LLC now owns 14,229 shares of the industrial products company’s stock worth $1,700,000 after buying an additional 101 shares in the last quarter. Cidel Asset Management Inc. lifted its stake in shares of Xylem by 6.1% in the 2nd quarter. Cidel Asset Management Inc. now owns 1,868 shares of the industrial products company’s stock valued at $242,000 after acquiring an additional 108 shares during the last quarter. Finally, Harrington Investments INC boosted its holdings in shares of Xylem by 0.5% during the 2nd quarter. Harrington Investments INC now owns 21,962 shares of the industrial products company’s stock valued at $2,841,000 after acquiring an additional 120 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on XYL shares. Argus set a $170.00 target price on Xylem in a research report on Wednesday, October 29th. Barclays raised their price target on shares of Xylem from $165.00 to $172.00 and gave the company an “overweight” rating in a research note on Wednesday, October 29th. Citigroup boosted their price objective on shares of Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. TD Cowen increased their price objective on Xylem from $125.00 to $130.00 and gave the company a “hold” rating in a report on Tuesday, August 26th. Finally, UBS Group lifted their target price on Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, November 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $166.90.

Xylem Stock Performance

Shares of XYL opened at $149.68 on Thursday. The company has a current ratio of 1.96, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. The firm’s fifty day simple moving average is $146.02 and its two-hundred day simple moving average is $136.52. Xylem Inc. has a 12 month low of $100.47 and a 12 month high of $154.27. The stock has a market capitalization of $36.44 billion, a P/E ratio of 38.48, a price-to-earnings-growth ratio of 2.50 and a beta of 1.15.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The company had revenue of $2.27 billion for the quarter, compared to the consensus estimate of $2.22 billion. During the same period in the previous year, the business earned $1.11 EPS. The firm’s revenue was up 7.8% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. As a group, analysts predict that Xylem Inc. will post 4.65 EPS for the current year.

Insiders Place Their Bets

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the transaction, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at $413,861.72. This represents a 25.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the sale, the executive vice president owned 31,250 shares of the company’s stock, valued at $4,770,000. The trade was a 25.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 13,121 shares of company stock worth $1,982,459. Corporate insiders own 0.27% of the company’s stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.